Masonglory vs PMA Graphene Technology
FFTT and PMA side by side, both in industrials. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How FFTT and PMA compare
Masonglory grew revenue faster over the last twelve months (1.0% versus −56.8% for PMA Graphene Technology).
Masonglory keeps more of each dollar of sales as profit, with a net margin of −34.0% compared with −39.4% at PMA Graphene Technology.
Masonglory scores higher on the StockData Score (7 against 0 for PMA Graphene Technology), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | FFTT | PMA |
|---|---|---|
| Size and price | ||
| Share price | $3.87 | $1.35 |
| Change, 1 year | −68.6% | −38.6% |
| Beta (5Y) | 2.68 | 1.05 |
| Employees | 11 | 7 |
| StockData Score | ||
| Total score | 7 (better) | 0 |
| Valuation score | 0 | 0 |
| Growth score | 2 (better) | 0 |
| Performance score | 0 | 0 |
| Health score | 5 (better) | 0 |
| Dividend score | 0 | 0 |
| Growth | ||
| Revenue growth (TTM) | 1.0% (better) | −56.8% |
| Net income growth (TTM) | −727% | – |
| EPS growth (TTM) | 460% | – |
| Profitability | ||
| Gross margin | 4.4% (better) | −18.4% |
| Operating margin | −33.2% (better) | −37.4% |
| Net margin | −34.0% (better) | −39.4% |
| FCF margin | −24.6% | – |
| Return on equity | −135% | – |
| Return on invested capital | −135% | −53.4% (better) |
| Financial health | ||
| Debt / equity | 0.00 | – |
| Interest coverage | – | −15.8× |
| Current ratio | 3.13 (better) | 0.71 |
| Piotroski F-score | 4 (better) | 2 |
| Ownership | ||
| Held by institutions | 0.18% | 0.77% |
| Held by insiders | 51.7% | 68.1% |
| Insider net buying, 12 months | – | −$1.7M |
| Short interest, % of float | – | 2.9% |
Go deeper
- FFTT stock overview
- FFTT income statement
- FFTT valuation and score
- PMA stock overview
- PMA income statement
- PMA valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.